Showing 11 posts of 11 posts found.


AstraZeneca antibody fails to prevent COVID in exposed patients

June 15, 2021
Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial

AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …


Top Ten most popular articles on this week

December 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …


Regeneron announces initial clinical data for COVID-19 antibody cocktail

December 18, 2020
Medical Communications COVID-19, Regeneron, antibody

Regeneron Pharmaceuticals has announced that initial clinical data published in the New England Journal of Medicine shows that its antibody …


AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020
Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …


COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn

June 25, 2020
Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …


Biotech firm fined $3.5 million for animal mistreatment

May 23, 2016
Medical Communications, Sales and Marketing US department of agriculture, animal cruelty, animal mistreatment, antibody, santa cruz biotechnology, usda

A US-based biotechnology company has been fined $3.5 million by the US Department of Agriculture (USDA) for a case related …

Takeda image

Takeda buys license to ImmunoGen cancer tech

March 24, 2015
Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …

samsung image

BMS taps Samsung for antibody manufacturing

July 30, 2013
Manufacturing and Production BMS, Samsung, antibody

Bristol-Myers Squibb has given signed a 10-year contract with South Korea’s Samsung BioLogics for the manufacture of one of its …

Boehringer wins contract to make Servier’s gevokizumab

August 7, 2012
Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody

Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …

Astellas breaks ground on $95m antibody facility

January 20, 2011
Manufacturing and Production Agensys, Astellas, antibodies, antibody

Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …

Latest content